Phenylpiracetam is a synthetic derivative of piracetam, developed in Russia for its potent nootropic and psychostimulatory effects. It is thought to modulate neurotransmitter systems like dopamine and acetylcholine, but its relevance to core aging pathways is speculative. While it may support acute cognitive performance, there is no evidence it extends healthspan or has long-term benefits for healthy individuals.
Verdict
An experimental nootropic with unproven healthspan benefits and notable safety concerns.
HEALTHSPAN IMPACT
Experimental
RISK LEVEL
High
EVIDENCE GRADE
C
MONTHLY COST
$20 - $50
Protocol
- Take 100-200mg as needed for acute cognitive tasks, often cycled to avoid tolerance.
- Avoid taking late in the day due to its potent stimulatory effects on wakefulness.
Flags
- Banned by the World Anti-Doping Agency (WADA) as a performance-enhancing substance.
- Long-term safety profile in healthy humans is not established.
- Common side effects include insomnia, irritability, headache, and psychomotor agitation.
- Often sourced from unregulated vendors, raising concerns about purity and contaminants.
- Tolerance can develop quickly, encouraging cyclical rather than continuous use.